Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia
View ORCID ProfileRaquel Real, View ORCID ProfileAlejandro Martinez-Carrasco, View ORCID ProfileRegina H. Reynolds, View ORCID ProfileMichael A. Lawton, View ORCID ProfileManuela M. X. Tan, View ORCID ProfileMaryam Shoai, View ORCID ProfileJean-Christophe Corvol, View ORCID ProfileMina Ryten, View ORCID ProfileCatherine Bresner, View ORCID ProfileLeon Hubbard, View ORCID ProfileAlexis Brice, View ORCID ProfileSuzanne Lesage, View ORCID ProfileJohann Faouzi, View ORCID ProfileAlexis Elbaz, View ORCID ProfileFanny Artaud, View ORCID ProfileNigel Williams, View ORCID ProfileMichele T. M. Hu, View ORCID ProfileYoav Ben-Shlomo, View ORCID ProfileDonald G. Grosset, View ORCID ProfileJohn Hardy, View ORCID ProfileHuw R. Morris
doi: https://doi.org/10.1101/2022.05.23.22275465
Raquel Real
1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, UK
2UCL Movement Disorders Centre, University College London, London, UK
3Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
Alejandro Martinez-Carrasco
1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, UK
2UCL Movement Disorders Centre, University College London, London, UK
3Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
Regina H. Reynolds
3Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
4Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, UK
Michael A. Lawton
5Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Manuela M. X. Tan
6Department of Neurology, Oslo University Hospital, Oslo, Norway
Maryam Shoai
7Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK
8UK Dementia Research Institute, University College London, London, UK
Jean-Christophe Corvol
9Sorbonne Université, Institut du Cerveau et de la Moelle épinière - Paris Brain Institute - ICM, INSERM, CNRS, Paris, France
10Assistance Publique Hôpitaux de Paris, Department of Neurology, Hôpital Pitié-Salpêtrière, Paris, France
Mina Ryten
3Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
4Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, UK
11NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK
Catherine Bresner
12Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK
Leon Hubbard
12Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK
Alexis Brice
9Sorbonne Université, Institut du Cerveau et de la Moelle épinière - Paris Brain Institute - ICM, INSERM, CNRS, Paris, France
10Assistance Publique Hôpitaux de Paris, Department of Neurology, Hôpital Pitié-Salpêtrière, Paris, France
Suzanne Lesage
9Sorbonne Université, Institut du Cerveau et de la Moelle épinière - Paris Brain Institute - ICM, INSERM, CNRS, Paris, France
10Assistance Publique Hôpitaux de Paris, Department of Neurology, Hôpital Pitié-Salpêtrière, Paris, France
Johann Faouzi
9Sorbonne Université, Institut du Cerveau et de la Moelle épinière - Paris Brain Institute - ICM, INSERM, CNRS, Paris, France
13Centre Inria de Paris, Paris, France
Alexis Elbaz
14Centre for Research in Epidemiology and Population Health, INSERM U1018, Team “Exposome, heredity, cancer, and health”, Villejuif, France
Fanny Artaud
14Centre for Research in Epidemiology and Population Health, INSERM U1018, Team “Exposome, heredity, cancer, and health”, Villejuif, France
Nigel Williams
12Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK
Michele T. M. Hu
15Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology, University of Oxford, Oxford, UK
16Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, UK
Yoav Ben-Shlomo
5Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Donald G. Grosset
17School of Neuroscience and Psychology, University of Glasgow, Glasgow, UK
John Hardy
3Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
7Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK
8UK Dementia Research Institute, University College London, London, UK
18Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK
19National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK
20Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China
Huw R. Morris
1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, UK
2UCL Movement Disorders Centre, University College London, London, UK
3Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
Article usage
Posted May 25, 2022.
Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia
Raquel Real, Alejandro Martinez-Carrasco, Regina H. Reynolds, Michael A. Lawton, Manuela M. X. Tan, Maryam Shoai, Jean-Christophe Corvol, Mina Ryten, Catherine Bresner, Leon Hubbard, Alexis Brice, Suzanne Lesage, Johann Faouzi, Alexis Elbaz, Fanny Artaud, Nigel Williams, Michele T. M. Hu, Yoav Ben-Shlomo, Donald G. Grosset, John Hardy, Huw R. Morris
medRxiv 2022.05.23.22275465; doi: https://doi.org/10.1101/2022.05.23.22275465
Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia
Raquel Real, Alejandro Martinez-Carrasco, Regina H. Reynolds, Michael A. Lawton, Manuela M. X. Tan, Maryam Shoai, Jean-Christophe Corvol, Mina Ryten, Catherine Bresner, Leon Hubbard, Alexis Brice, Suzanne Lesage, Johann Faouzi, Alexis Elbaz, Fanny Artaud, Nigel Williams, Michele T. M. Hu, Yoav Ben-Shlomo, Donald G. Grosset, John Hardy, Huw R. Morris
medRxiv 2022.05.23.22275465; doi: https://doi.org/10.1101/2022.05.23.22275465
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11650)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3654)
- Geriatric Medicine (343)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)